The FDA also conducted a review of the medical literature on statins and found that, in a meta-analysis conducted on statin trials, together totalling 91,140 participants, statin therapy was associated with a 9% risk increase for incident diabetes. Another meta-analysis with 57,593 participants also reported a small increased risk of diabetes. Data from Women's Health Initiative also confirmed that statin use is related to increased risk for new-onset diabetes in postmenopausal women. This study reported that "...the effect appears to be a medication class effect, unrelated to potency or to individual statin."
The above findings have led to the initiation of lawsuits against Lipitor and Crestor. Lawyers are currently reviewing statin data and Lipitor type 2 diabetes side effect claims. For information on these lawsuits, see source 1, source 2, source 3, source 4, source 5.
Statins May Raise Diabetes Risk in Older Women